Evidence-Based Therapies for Chronic Migraine in 2026

Evidence-Based Therapies for Chronic Migraine in 2026: What the Research Actually Supports

Chronic migraine is a complex neurological disorder requiring individualized care. This 2026 review outlines therapies ranging from CBT and mindfulness to CGRP medications and neuromodulation devices, emphasizing integrated treatment plans that combine medical and behavioral approaches for better long-term outcomes.

By 
Lin Health
Reviewed by 
June 9, 2026
13
 min. read

Chronic migraine is more than frequent headaches. It is a distinct neurological condition, and the people living with it often cycle through several treatments before finding a combination that helps. The good news in 2026 is that the evidence base has grown in two directions at once: newer preventive medications, and a stronger case for behavioral and lifestyle care that many patients can start right away.

This guide walks through the therapies with the most credible research behind them. It is written for someone living with chronic migraine, and for the clinician who may be deciding what to recommend next. Where the evidence is strong, this guide says so. Where it is promising but still limited, it says that too.

Key Takeaways

  • Chronic migraine is defined as headache on 15 or more days a month for over three months, with at least 8 days meeting full migraine criteria.
  • Behavioral therapy carries a Grade A evidence rating in US headache guidelines, with cognitive behavioral therapy, relaxation training, and biofeedback as the main approaches, though a 2025 review rated the current certainty of evidence as low.
  • CGRP-targeting medications are now considered a first-line preventive option, a notable change from earlier guidance.
  • For many people, the most durable plans combine a preventive medication with behavioral skills, regular exercise, and trigger management, rather than relying on any single therapy.
  • Lin Health's coach-led approach is based on findings from behavioral and neuroplastic pain research, and is covered by most major insurance plans in its highest-coverage states.

How Chronic Migraine Is Defined

Chronic migraine has a specific clinical definition. It means headache on at least 15 days per month for more than three months, with at least 8 of those days meeting the criteria for migraine. That distinguishes it from episodic migraine, where attacks happen less often.

The scale of the problem is large. Migraine affects roughly 12% of US adults, and chronic migraine affects close to 1% of adults, with women affected more often than men. For many of those people, attacks are disabling enough to interfere with work, family, and daily life.

One practical caution shapes every treatment plan. Frequent use of acute pain medication can lead to medication-overuse headache, which is a common complicating factor in chronic migraine. That is part of why prevention, not just attack relief, sits at the center of good care.

A quick note on how to read the rest of this guide. The therapies below are grouped from approaches a person can often begin alongside their current care, through to medical and device options that need a prescribing clinician. Strong research support does not mean a therapy works for everyone, and most people do best with a combination chosen with their clinician.

1. Cognitive Behavioral Therapy (CBT)

Cognitive behavioral therapy is a structured, skills-based talk therapy. For migraine, it focuses on stress responses, sleep and routine, pain-related thoughts, and the behaviors that can feed the cycle of frequent attacks.

What the evidence shows

Behavioral therapy carries a Grade A evidence rating for migraine prevention in US headache guidelines, with CBT among the main approaches. A 2025 systematic review took a more conservative view: it found that CBT may reduce headache frequency, but rated the strength of that evidence as low, largely because many trials were small or at risk of bias. Both things are true at once, and a clinician reading this guide should know both.

Who it may fit

CBT is often a good fit for people who want active skills they can use between attacks, those who prefer to avoid or reduce medication, and anyone whose migraines are closely tied to stress, sleep disruption, or anxiety. It can be used on its own or alongside preventive medication. Lin Health applies evidence-based CBT approaches within its coaching programs.

2. Relaxation Training and Biofeedback

Relaxation training teaches the nervous system to down-shift on purpose, using techniques such as paced breathing, progressive muscle relaxation, and guided imagery. Biofeedback adds real-time signals, such as muscle tension or skin temperature, so a person can see their body respond as they practice.

What the evidence shows

Relaxation training may reduce attack frequency in adults with migraine, and it shares the historical Grade A designation noted above. Worth a clear-eyed note for clinicians: in the same 2025 review, biofeedback as a standalone intervention had insufficient evidence to draw a firm conclusion, even though it remains widely used and is often delivered together with relaxation and CBT rather than alone.

Who it may fit

These techniques may suit people who carry physical tension, who want a portable tool they can use during an attack or to prevent one, and people who are pregnant or who do not tolerate medications well, since behavioral options avoid medication exposure. Many programs teach relaxation and CBT as a single package.

3. Mindfulness-Based Approaches

Mindfulness-based approaches, including mindfulness-based stress reduction, train attention toward present-moment experience and a less reactive relationship with pain. The goal is not to make pain vanish on command, but to reduce its grip on daily functioning.

What the evidence shows

In a randomized trial of adults with migraine, mindfulness-based stress reduction did not lower frequency more than headache education. Both groups improved on that measure. What set mindfulness apart was its effect on the burden of the condition: it improved disability, quality of life, self-efficacy, pain catastrophizing, and depression, with benefits lasting out to 36 weeks. The 2025 systematic review similarly found mindfulness may reduce disability and headache frequency, again at low certainty.

Who it may fit

Mindfulness may be most valuable for people whose migraines come with significant distress, low mood, or a sense that pain runs their life, where reducing the total burden matters as much as the day count. Lin Health includes mindfulness within its programs, and its clinical network has explored mindfulness and chronic pain in depth.

4. Aerobic Exercise

Regular exercise, such as brisk walking, cycling, swimming, or light strength work, is among the most accessible self-care strategies for migraine, and it is widely recommended as part of a prevention plan.

What the evidence shows

The evidence here is genuinely mixed. A 2025 network and dose-response meta-analysis found that exercise may reduce migraine burden, with combined aerobic and strength training showing the strongest signal, while aerobic exercise alone did not reach statistical significance in that analysis. The suggested dose was roughly 70 to 135 minutes of moderate-intensity activity per week, sustained over 8 to 10 weeks. The certainty of this evidence was low, so exercise is best understood as a supportive part of a plan rather than a standalone fix.

Who it may fit

Exercise may help most people with chronic migraine as part of a broader plan, though for some, exertion can be a trigger. A graded start, building up slowly with guidance, helps manage that. It pairs naturally with the behavioral approaches above.

5. CGRP-Targeting Preventive Therapies

The biggest pharmacologic shift of recent years involves drugs that target calcitonin gene-related peptide (CGRP), a molecule central to migraine attacks. This category includes injectable monoclonal antibodies and oral medications called gepants.

What the evidence shows

In 2024, the American Headache Society stated that CGRP-targeting therapies should be considered a first-line option for migraine prevention. That is a meaningful change. Earlier guidance asked patients to try and fail at least two older preventive classes first; the updated position removes that requirement, based on the volume and quality of evidence for these drugs.

Who it may fit

CGRP therapies are a prescription decision made with a neurologist or headache specialist. They are often considered for people with frequent, disabling migraine, including chronic migraine, and for those who have not tolerated or responded to older preventives. A specialist can weigh the options, including dedicated headache centers such as the NY Headache Center.

6. Established Oral Preventive Medications

Before CGRP therapies, several oral medications formed the backbone of migraine prevention, and they remain useful and widely prescribed.

What the evidence shows

Medications including topiramate, propranolol, metoprolol, and divalproex carry Level A evidence for preventing episodic migraine. For chronic migraine specifically, onabotulinumtoxinA and the CGRP therapies above have the most dedicated evidence, and topiramate is also commonly used. Each oral preventive has its own side-effect profile, which shapes the choice.

Who it may fit

These medications may suit people who also have a condition the drug treats, such as high blood pressure with a beta-blocker, or who prefer a low-cost oral option. The fit depends on other health conditions, pregnancy plans, and tolerance, so this is a conversation with a prescriber.

7. Non-Invasive Neuromodulation Devices

Neuromodulation devices use mild electrical or magnetic signals to influence the nerve pathways involved in migraine. Several are FDA-cleared and available with a prescription or over the counter, depending on the device.

What the evidence shows

The 2025 International Headache Society guideline gave conditional recommendations in favor of several non-invasive devices for acute or preventive migraine treatment. FDA-cleared options include external trigeminal nerve stimulation (Cefaly), remote electrical neuromodulation worn on the arm (Nerivio), and non-invasive vagus nerve stimulation (gammaCore). The recommendations are described as weak or conditional, meaning the devices may help but the certainty is moderate.

Who it may fit

Devices may appeal to people who want a drug-free option, who cannot tolerate medications, or who want to add a tool to an existing plan. Because clearances and coverage vary by device and age group, a headache clinician can help match the device to the person.

How Lin Health Helps With Chronic Migraine

Most of the therapies above are not either-or choices. The plans that hold up over time tend to combine a medical preventive, chosen with a clinician, with behavioral skills, movement, and trigger management that a person practices day to day. That second half is exactly where coordinated, coach-led care earns its place, and where many patients have the hardest time finding consistent support.

Lin Health's approach is based on findings from research on behavioral therapies and neuroplastic pain, the science of how the nervous system can keep a pain alarm switched on. The program brings several of the behavioral approaches in this guide into one place:

  • A trained recovery coach who works with you over time, not a one-off appointment
  • Skills from CBT, relaxation training, mindfulness, and somatic tracking, matched to your situation
  • Lifestyle and trigger support, including the kind of trigger work that helps reduce attack frequency over time
  • An app that supports practice between sessions

Two practical points matter for access. Lin Health is covered by most major insurance plans, with the strongest coverage in Colorado, Texas, Florida, California, and New York. Wait times are short, often a same-day call. To learn more, read Lin Health's chronic migraine guide and its approaches to migraine prevention.

Behavioral care is meant to work alongside your medical treatment, not replace it. If you have tried medications and still have frequent migraine days, adding structured behavioral support may be worth considering. Explore Lin Health and check your insurance eligibility, most patients pay zero out of pocket.

FAQ

Which therapy has the strongest evidence for chronic migraine?

There is no single answer that fits everyone. CGRP-targeting medications are now a first-line preventive option, and behavioral therapies like CBT have strong guideline support. For many people, a combination of a preventive medication and behavioral skills works better than either alone. The right plan depends on your history, other health conditions, and what you can sustain.

Can chronic migraine be treated without medication?

For some people, yes, at least in part. Behavioral therapies, regular exercise, and neuromodulation devices are drug-free options with some research support, and they may reduce attack burden. Many people still benefit from combining them with a preventive medication. Talk with a clinician before changing or stopping any treatment.

Does cognitive behavioral therapy actually work for migraine?

CBT carries a long-standing Grade A designation for migraine prevention, and a 2025 review found it may reduce attack frequency, though it rated the certainty as low. CBT will not cure migraine, but it may reduce how often attacks happen and how much they disrupt daily life, especially when stress or sleep is involved.

Are CGRP medications better than older preventives?

CGRP-targeting therapies are now considered first-line, without needing to fail older drugs first. That reflects strong evidence for their effect and tolerability. Older oral preventives still carry Level A evidence and remain useful, often at lower cost. A specialist can help weigh side effects, cost, and your other conditions.

How long does it take for migraine therapies to work?

It varies by therapy. Preventive medications are often given a trial of about 8 to 12 weeks before judging effect. Behavioral therapies build skills over a course of weeks and may keep helping after the program ends. Exercise benefits tend to accrue with consistent practice over months, not days.

Is behavioral therapy for migraine covered by insurance?

It can be. Coverage varies by plan, state, and provider. Lin Health is in-network with most major insurance plans and has its strongest coverage in Colorado, Texas, Florida, California, and New York. The most reliable way to know your cost is to check your specific plan and eligibility directly.

The Bottom Line

Chronic migraine care in 2026 has more credible options than ever, spanning behavioral therapy, exercise, newer first-line preventive medications, and FDA-cleared devices. The strongest plans usually combine a medical preventive with the behavioral and lifestyle skills a person can practice every day. If you are looking for that second half of the plan, coach-led behavioral support may help, and it is worth asking whether it is covered by your insurance.

This article is for informational purposes and is not medical advice. It does not replace care from a qualified healthcare provider. Talk with your clinician before starting, stopping, or changing any treatment for migraine.

Start finding real relief from chronic pain today - give Lin a try.

Get in touch

Behavioral Healthcare for Pain

Learn more about our treatment

Join thousands of Lin members and reclaim your life from pain

Get in touch

Don’t miss a thing!

Know more, feel better. Sign up for our newsletter and keep up with the latest in pain science.

Not ready yet?

Check out our Free Resource Center with lessons & exercises to learn more about the latest science behind chronic pain.

Check out our Free Resource Center with lessons & exercises to learn more about the latest science behind chronic pain.

Take me there
Charlie Merrill / PT and clinical advisor
Live podcast

Join leading PhD researcher & pain psychologist for an outstanding conversation

Healing Chronic Back Pain: The active ingredients

Charlie Merrill / PT and clinical advisor
Wed
Nov 2
1-2pm EST/10-11am PST
Join now
Charlie Merrill / PT and clinical advisor
FREE: Exclusive round table

Join leading PhD researcher & pain psychologist for an outstanding conversation

The truth about fibro recovery

Charlie Merrill / PT and clinical advisor
Wed
Oct 26
1-2pm EST/10-11am PST
Join now